RE
ATRS

RBC Europe’s Antares Pharma, Inc. ATRS Stock Holding History

RBC Europe’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,275
Closed -$8.28K – 1265
2021
Q3 		$8.28K Hold
2,275
– – ﹤0.01% 968
2021
Q2 		$9.92K Hold
2,275
– – ﹤0.01% 954
2021
Q1 		$9.35K Hold
2,275
– – ﹤0.01% 922
2020
Q4 		$9.08K Hold
2,275
– – ﹤0.01% 895
2020
Q3 		$6.14K Hold
2,275
– – ﹤0.01% 881
2020
Q2 		$6.26K Hold
2,275
– – ﹤0.01% 843
2020
Q1 		$5.37K Hold
2,275
– – ﹤0.01% 822
2019
Q4 		$10.7K Hold
2,275
– – ﹤0.01% 790
2019
Q3 		$7.61K Hold
2,275
– – ﹤0.01% 837
2019
Q2 		$7.49K Hold
2,275
– – ﹤0.01% 863
2019
Q1 		$6.89K Hold
2,275
– – ﹤0.01% 888
2018
Q4 		$6.19K Hold
2,275
– – ﹤0.01% 889
2018
Q3 		$7.64K Hold
2,275
– – ﹤0.01% 900
2018
Q2 		$5.87K Hold
2,275
– – ﹤0.01% 941
2018
Q1 		$5K Hold
2,275
– – ﹤0.01% 945
2017
Q4 		$4.53K Hold
2,275
– – ﹤0.01% 970
2017
Q3 		$7.37K Buy
+2,275
New +$7.02K ﹤0.01% 897

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

RBC Europe's ATRS Position: Q4 2021 in Review

RBC Europe sold out of Antares Pharma, Inc. (ATRS) in Q4 2021, closing a stake of 2,275 shares — an estimated $8.28K sold.

RBC Europe first reported a position in ATRS in Q3 2017 and held it in 17 quarters. The position peaked at $10.7K in Q4 2019. 162 funds tracked by Wall St. Rank hold ATRS as of Q4 2021.

  • RBC Europe reported no remaining Antares Pharma, Inc. position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 2,275 Antares Pharma, Inc. shares in Q4 2021, an estimated $8.28K.
  • RBC Europe first reported a position in Antares Pharma, Inc. in Q3 2017 and held it in 17 quarters.
  • RBC Europe's Antares Pharma, Inc. position peaked at $10.7K in Q4 2019.
  • 162 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.